Estimating the weighted prevalence of anxiety disorders in breast cancer patients using a Two-stage approach

Authors

  • Olamijulo A Fatiregun Department of Psychiatry, Lagos University Teaching Hospital, Idi-araba, Lagos.
  • Oluseun Peter Ogunnubi Department of Psychiatry, College of Medicine, University of Lagos, Idi-Araba, Lagos http://orcid.org/0000-0001-9733-6325
  • Omolara A Fatiregun Oncology Unit, Lagos State University Teaching Hospital, Ikeja. Lagos, Nigeria
  • Bolutife O Oyatokun Department of Psychiatry, Lagos University Teaching Hospital, Idi-araba, Lagos, Nigeria
  • Osunwale Dahunsi Oni Department of Psychiatry, Lagos University Teaching Hospital, Idi-araba, Lagos, Nigeria
  • Adebayo R Erinfolami Lagos University Teaching Hospital, and Senior Lecturer, Department of Psychiatry, College of Medicine, University of Lagos, Idi-araba, Lagos, Nigeria.
  • Joseph D Adeyemi Lagos University Teaching Hospital, and Department of Psychiatry, College of Medicine, University of Lagos, Idi-araba, Lagos, Nigeria.

DOI:

https://doi.org/10.30442/ahr.0401-1-02

Keywords:

Anxiety disorder, Two-stage Survey, Breast cancer, Pattern

Abstract

Background: A two-stage survey is useful when the actual diagnostic interview is time-consuming and expensive to administer on the general population.

Objective: To compare Schedule for Clinical Assessment in Neuropsychiatry (SCAN) with Hospital Anxiety and Depression Scale (HADS) in the determination of the prevalence of anxiety disorder in patients with breast cancer.

Methods: A cross-sectional study of 200 female patients diagnosed with breast cancer attending the Oncology Out-Patients Clinic of the Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria was done. The instruments used for the survey included a socio-demographic questionnaire, the HADS and the SCAN.

Results: The mean age of the subjects was 49.6 ± 11.2 years. Majority of the subjects (76.5%) were married. Using HADS with a threshold score of ≥ 8, 53 (26.5%) met the criteria for probable anxiety disorders (herein called ‘cases’). Of the 68 patients (all 53 ‘cases’ plus 15 randomly selected 10% of the non-cases) interviewed with the SCAN instrument, only 38 met the criteria for diagnosis of anxiety disorder.

Conclusions: The prevalence of anxiety disorders can be determined with greater precision using the two-stage design approach. Diagnostic tools like SCAN should therefore be incorporated in the assessment protocols for patients with breast cancer and other illnesses.

Author Biographies

Olamijulo A Fatiregun, Department of Psychiatry, Lagos University Teaching Hospital, Idi-araba, Lagos.

Consultant Psychiatrist, Department of Psychiatry, Lagos University Teaching Hospital, Idi-araba, Lagos.

Oluseun Peter Ogunnubi, Department of Psychiatry, College of Medicine, University of Lagos, Idi-Araba, Lagos

Lecturer I, Department of Psychiatry, College of Medicine, University of Lagos.

Omolara A Fatiregun, Oncology Unit, Lagos State University Teaching Hospital, Ikeja. Lagos, Nigeria

Consultant Oncologist, Oncology Unit, Lagos State University Teaching Hospital, Ikeja. Lagos, Nigeria

Bolutife O Oyatokun, Department of Psychiatry, Lagos University Teaching Hospital, Idi-araba, Lagos, Nigeria

Senior Registrar, Department of Psychiatry, Lagos University Teaching Hospital, Idi-araba, Lagos, Nigeria

Osunwale Dahunsi Oni, Department of Psychiatry, Lagos University Teaching Hospital, Idi-araba, Lagos, Nigeria

Department of Psychiatry, Lagos University Teaching Hospital, Idi-araba, Lagos, Nigeria

Adebayo R Erinfolami, Lagos University Teaching Hospital, and Senior Lecturer, Department of Psychiatry, College of Medicine, University of Lagos, Idi-araba, Lagos, Nigeria.

Consultant Psychiatrist, Lagos University Teaching Hospital, and Senior Lecturer, Department of Psychiatry, College of Medicine, University of Lagos, Idi-araba, Lagos, Nigeria.

Joseph D Adeyemi, Lagos University Teaching Hospital, and Department of Psychiatry, College of Medicine, University of Lagos, Idi-araba, Lagos, Nigeria.

Consultant Psychiatrist, Lagos University Teaching Hospital, and Professor, Department of Psychiatry, College of Medicine, University of Lagos, Idi-araba, Lagos, Nigeria. Email:

References

Alonzo TA, Pepe MS, Lumley T. Estimating disease prevalence in two-phase studies. Biostatistics. 2003; 4(2): 313–326.

Leung DHY, Qin J. Semiparametric prevalence estimation from a two-phase survey. 18th World IMACS / MODSIM Congress: Cairns; 2009.

Dunn G, Pickles A, Tansella M, Vazquez-Barquero J. Two-phase epidemiological surveys in psychiatric research. British Journal of Psychiatry. 1999; 174: 95-100.

Gao S, Hui SL, Hall KS, Hendrie HC. Estimating disease prevalence from two-phase surveys with non-response at the second phase. Statist. Med. 2000; 19: 2101-2114.

Beckett LA, Scherr PA, Evans DA. Population prevalence estimates from complex samples. Journal of Clinical Epidemiology. 1992; 45: 393-402.

Warszawski J, Messiah A, Lellouch J, Meyer L, Deville JC. Estimating means and percentages in a complex sampling surveys: application to a French national survey on sexual behaviour. Statistics in Medicine. 1997;16: 397- 423.

Chambless LE, Boyle KE. Maximum likelihood methods for complex sample data: logistic regression and discrete proportional hazard models. Communications in Statistics — Theory and Methods. 1985; 14: 1377-1392.

McNamee R. Efficiency of two-phase designs for prevalence estimation. Int J Epidemiol. 2003; 32: 1072–78.

Kalbfleisch JD, Lawless JF. Likelihood analysis of multi-state models for disease incidence and mortality. Statist. Med. 1988;7:149–160. doi:10.1002/sim.4780070116.

Lehtonen R, Pahicinen E. Practical Methods for Design and Analysis of Complex Surveys. Chichester: Wiley; 1995.

Ohaeri JU, Campbell OB, Lola OD. The emotional dispositional of terminally ill Nigerian patients to their condition. Orient Journal of Medicine. 1993; 5(4): 115-117.

Nuhu FT. Depression and quality of life of cancer patients: A dissertation submitted to the National Postgraduate Medical College of Nigeria in partial fulfillment of the requirement for the award of fellowship of the Faculty of Psychiatry. Lagos; 2007.

Olagunju O. Depression Among Cancer Patients Attending Oncology Clinic in Lagos University Teaching Hospital. A dissertation submitted to the National Postgraduate Medical College of Nigeria in partial Fulfilment of the requirement for the award of fellowship of the Faculty of Psychiatry. Lagos; 2010.

Popoola AO, Adewuya OA. Prevalence and correlates of depressive disorders in outpatients breast cancer. Psycho-Oncology. 2012; 21(6): 675-9.

Nuhu FT, Odejide OA, Adebayo KO, Yusuf AJ. Psychological and physical effect of pain on cancer patients in Ibadan, Nigeria. African Journal of Psychiatry. 2009; 12(1): 65-70.

Phoon WO. Epidemiology for health officer: a field manual for the tropics. Department of Social Medicine and Public Health, National University of Singapore; 1986.

Araoye MO. Research Methodology with Statistics for Health and Social Sciences. Nathadex publishers; 2004: 117-120.

Beekman A, Marijke A, Deeg D, Anton J, Balkom V, Smith J, Beurs E, Dyek R, Tilburg W, Anxiety disorders in later life, a report from the longitudinal aging study Amsterdam. International Journal of Geriatric Psychiatry. 1998; 13: 717-726.

Duran B, Sanders M, Skipper B, Waitzkin H, Malcoe HL, Paine S, Yager J. Prevalence and correlates of mental disorders among native American women in primary care. Am J Public Health. 2004; 94(1): 71–77.

International Labour Organization. International Standard Classification of Occupations (ISCO-08) Conceptual Framework. ILO, 2008(http://www.ilo.org/public/english/bureau/stat/isco/docs/annex1.doc).

Zigmond AS, Snaith RP. The hospital anxiety and depression scales. Acta. Psychiatry. Scand. 1983; 67: 361-370.

Ryde-Brandt B. Anxiety and depression in mothers of children with psychotic disorders and mental retardation. Br J Psychiatry. 1990; 156: 118-21.

Abiodun OA. A validity study of the Hospital Anxiety and Depression Scale in general hospital units and a community sample in Nigeria. BJP. 1994; 165: 669-672.

World Health Organization. Schedule for Clinical Assessment in Neuropsychiatry (SCAN). World Health Organization Assessment, Classification and Epidemiology, Geneva; 1999.

Prince M. Commentary: Two-phase surveys. A death is announced; no flowers please. Int. J. Epidemiol. 2003; 32(6): 1078-1080.

Published

2018-06-17

Issue

Section

Original Research